Geode Capital Management, LLC Xeris Biopharma Holdings, Inc. Call Options Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding XERS
# of Institutions
139Shares Held
56.8MCall Options Held
126KPut Options Held
45K-
Black Rock Inc. New York, NY10.3MShares$32.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$24.5 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$16.1 Million61.49% of portfolio
-
State Street Corp Boston, MA3.26MShares$10.3 Million0.0% of portfolio
-
Aigh Capital Management LLC Baltimore, MD2.19MShares$6.88 Million2.52% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $428M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...